Gilead Sciences Statement on Report About Remdesivir in China

(Bloomberg) -- Here is the full text of an emailed statement from Gilead Sciences Inc. after reports that the company’s experimental drug being tested in severe Covid-19 patients failed to show a p...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.